Endometriosis is a painful, common condition affecting women worldwide, but treatment and diagnosis options are scarce. A new University of Mississippi-led study may have found an answer to both problems.

Study suggests that magnetic surfaces may influence not only the handedness of biological molecules but also their isotope composition – thus connecting two fundamental fingerprints of life

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates and was associated with significantly lower mortality, according to new research published in the INFORMS journal Manufacturing & Service Operations Management.

A new paper published in Strategic Management Journal finds that startup accelerators do not level the entrepreneurial playing field, they amplify it. The study, “Founders’ Pre-Entry Knowledge and the Heterogeneous Returns to Accelerator Participation,” by Melody H. Chang and Valentina A. Assenova, shows that founders with deeper prior knowledge gain disproportionately more from accelerator participation, while novice founders see more modest benefits. Drawing on data from 6,723 startups across 281 accelerators in 147 countries, the authors find that accelerators “push up the ceiling” of performance for already capable teams without necessarily “pulling up the floor” for others.

A collaborative research team led by Professor Hyun Koo Kim of Korea University College of Medicine has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and predicting patient prognosis.

Recently, a team at Soochow University integrated computational fluid dynamics with fluid-structure interaction modeling to quantify WSS in 33 AD patients and 25 controls, revealing a 2-fold higher peak WSS in AD patients that strongly correlated with AD initiation and progression. To mimic AD-relevant WSS microenvironments, they developed an AD-specific organ-on-a-chip (OOC) system, which recapitulated key AD pathologies, including mitochondrial dysfunction, smooth muscle cell (SMC) phenotypic switching, and abnormal mechanotransduction.

Researchers at the Mount Sinai Tisch Cancer Center have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors, a widely used class of targeted cancer therapies.